Elsevier

Biological Psychiatry

Volume 32, Issue 9, 1 November 1992, Pages 812-816
Biological Psychiatry

Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression

https://doi.org/10.1016/0006-3223(92)90084-DGet rights and content

Abstract

Hypothalamic-pituitary-adrenal (HPA) axis function was examined in relation to suicidal behavior in depression. There were no significant differences between depressed patients who had or had not attempted suicide for either cerebrospinal fluid concentrations of corticotropin-releasing hormone, plasma cortisol levels predexamethasone or postdexamethasone, or for urinary-free cortisol outputs. However, depressed patients who had made a violent suicide attempt had significantly higher 4 pm and maximum postdexamethasone plasma cortisol levels, and significantly more of them were cortisol nonsuppressors than patients who had made nonviolent suicide attempts. A 5-year follow-up was carried out. There were no significant differences on indices of HPA function between depressed patients who did or did not reattempt suicide during the follow-up or who had never attempted suicide. These results suggest the possibility that dysregulation of the HPA axis may be a determinant of violent suicidal behavior in depression.

References (19)

There are more references available in the full text version of this article.

Cited by (96)

  • Blood hormones and suicidal behaviour: A systematic review and meta-analysis

    2022, Neuroscience and Biobehavioral Reviews
    Citation Excerpt :

    This study was performed by Stata SE 12.0, using metan package, metareg package, metafunnel and metabias packages. In total, a systematic search yielded 3393 studies for eligibility, of which 57 ultimately met criteria for inclusion (Atmaca et al., 2003, 2002, 2006, 2008; Ayesa-Arriola et al., 2018; Ayuso-Gutiérrez et al., 1987; Bendix et al., 2017; Brown et al., 1986; Brunner et al., 2002, 2001; Chang et al., 2017; Chatzittofis et al., 2013; Corrêa et al., 2000; da Graça Cantarelli et al., 2015; Deisenhammer et al., 2012; Duval et al., 2001, 2010; Fang et al., 2019; Ge et al., 2020; Herranz-Herrer et al., 2020; Inder et al., 1997; Jahangard et al., 2020, 2018; Jose et al., 2015; Keilp et al., 2010; Keshri et al., 2018; Kim et al., 2013; Li et al., 2020, 2021; Liu et al., 2021a, 2022, 2021b; Ma et al., 2019; Marcinko et al., 2005; Markianos et al., 2009; Martin et al., 1997; McGirr et al., 2011; Ozcan et al., 2016; Papadopoulou et al., 2017; Peng et al., 2018; Perez-Rodriguez et al., 2011; Pitchot et al., 1995, 2005; Płocka-Lewandowska et al., 2001; Pompili et al., 2012; Prochazka et al., 2000; Roy, 1992; Sáiz et al., 1997; Secunda et al., 1986; Shen et al., 2019; Sher et al., 2020, 2018; Stefansson et al., 2016; Su et al., 2019; Tripodianakis et al., 2007; Westrin et al., 1999; Zhou et al., 2021) (Fig. 1). Fifty-one articles evaluated suicide attempts, and 9 assessed suicidal ideation.

  • Bipolar disorders, obesity, and metabolic disturbances: Mechanisms and implications

    2020, Neurobiology of Bipolar Disorder: Road to Novel Therapeutics
View all citing articles on Scopus
1

Thanks to Philip Gold, M.D. for the assay of CSF CRH, to Simcha Pollack, Ph.D. for statistical help, and to an anonymous reviewer for suggesting examining serious suicide attempts.

View full text